• Bogusław Buszewski, Agnieszka Ulanowska, Tomasz Kowalkowski, and Krzysztof Cieśliński.
• Faculty of Chemistry, Nicolaus Copernicus University, Torun, Poland. bbusz@chem.umk.pl
• Clin Chem Lab Med. 2011 Oct 28; 50 (3): 573-81.

BackgroundVolatile organic compounds (VOCs) present in breath of lung cancer patients and released by lung cancer cells were determined. As a reference sample breath collected from healthy volunteers and lung segments of cells with proper morphology were used.MethodsSolid phase microextraction and gas chromato-graphy mass spectrometry (SPME-GC/MS) method was applied for VOC analysis. Statistical methods have been developed to find similarities between patterns of investigated compounds within three populations of samples: exhaled air samples from patients with lung cancer, headspace of lung tissues with healthy and cancer cells.ResultsQuantitative analysis of VOCs in the headspace of lung tissues revealed that cancer cells released higher concentrations of ethanol, acetone, carbon disulfide, dimethyl sulfide, 1-propanol, 2-propanol, 2-butanone and 2-pentanone than healthy tissues. The increase of concentration of the same compounds was observed in the breath of patients with lung cancer in comparison to breath from healthy non-smoking volunteers.ConclusionsDetection of lung cancer is possible by volatile biomarkers analysis in breath.

24 keywords...

hide…